SNDX
Syndax Pharmaceuticals Inc
NASDAQ · Healthcare · Biotechnology · US
$10.33
−27.72%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 65.34x
- P/S forward
- 2.31x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -54.10x
- Price / sales
- 3.21x
- Price / cash flow
- -5.24x
Enterprise value
- Enterprise value
- $1.1B
- EV / sales
- 3.77x
- EV / EBITDA
- -9.15x
- EV / EBIT
- -6.11x
- Market cap
- $929.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026